YahooOctober 27, 2026 at 7:56 AM NY4 Hours Ago
Is Merck Stock a Buy, Sell or Hold Ahead of Q3 Earnings?
MRK heads into Q3 earnings with strong Keytruda sales and new drug growth, but declining estimates, Gardasil weakness and looming patent risks cloud its outlook.
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Yahoo
